Related Experiment Video
Updated: Feb 18, 2026

07:47
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.3K
mSignatureDB: a database for deciphering mutational signatures in human cancers.
Po-Jung Huang1,2, Ling-Ya Chiu3, Chi-Ching Lee2,4
1Department of Biomedical Sciences, Chang Gung University, Taoyuan, Taiwan.
Nucleic Acids Research
|November 18, 2017
Summary
Understanding cancer
Area of Science:
- Genomics
- Cancer Research
- Bioinformatics
Background:
- Cancer arises from somatic mutations, but the biological processes causing them are not fully understood.
- Cancer genomes accumulate mutations during tumor development, making mutational signature analysis crucial.
- Existing databases like COSMIC require large cohorts and bioinformatics expertise, limiting accessibility for custom analyses.
Purpose of the Study:
- To develop a user-friendly database for analyzing mutational signatures in cancer.
- To enable quantification of known mutational signatures in individual tumors and custom cohorts.
- To facilitate accessible comparison of mutational signature patterns across diverse cancer projects.
Main Methods:
- Integrated R packages and in-house scripts for mutational signature analysis.
- Analyzed 15,780 tumors from 73 The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) projects.
- Developed mSignatureDB (http://tardis.cgu.edu.tw/msignaturedb) for signature quantification at sample resolution.
Main Results:
- mSignatureDB successfully quantified published mutational signatures across 73 cancer projects.
- Enabled within- and between-project comparisons of mutational signature patterns.
- Provided a unique capability for users to perform signature analysis on their own datasets.
Conclusions:
- mSignatureDB enhances accessibility for researchers studying cancer mutational signatures.
- The database facilitates detailed analysis of mutational processes across large cancer cohorts.
- Offers a novel tool for quantifying mutational signatures at the individual tumor level.

